Application
CREG2 Antibody (C-term) western blot analysis in A2058 cell line lysates (35ug/lane).This demonstrates the CREG2 antibody detected the CREG2 protein (arrow).Application
CREG2 Antibody (C-term) (AP14122b)immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of CREG2 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Product Name | CREG2 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | CREG2; Protein CREG2 |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WBIHC |
| WB:1:100~500 IHC |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Alternative Names | CREG2 Protein CREG2 |
|---|---|
| Molecular Weight(MW) | 32109 Da |
| Tissue Specificity | Brain specific mainly in the limbic system and faintly in the spinal cord but not in cerebellum |
| Cellular Localization | Secreted. |
| Entrez Gene | 200407 |
|---|---|
| Nucleotide Accession | NP_722578.1 |
Application
CREG2 Antibody (C-term) western blot analysis in A2058 cell line lysates (35ug/lane).This demonstrates the CREG2 antibody detected the CREG2 protein (arrow).
Application
CREG2 Antibody (C-term) (AP14122b)immunohistochemistry analysis in formalin fixed and paraffin embedded human brain tissue followed by peroxidase conjugation of the secondary antibody and DAB staining.This data demonstrates the use of CREG2 Antibody (C-term) for immunohistochemistry. Clinical relevance has not been evaluated.| Application Notes | WB:1:100~500 IHC |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
